{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:39:08Z","timestamp":1788669548017,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100032724","name":"Rajagiri College of Social Sciences","doi-asserted-by":"publisher","award":["Grant No.: RCSS\/IQAC\/BB-S171\/2026\/171"],"award-info":[{"award-number":["Grant No.: RCSS\/IQAC\/BB-S171\/2026\/171"]}],"id":[{"id":"10.13039\/100032724","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10787-026-02296-1","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:31:37Z","timestamp":1781533897000},"page":"4691-4719","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated in silico docking, ADMET, and network pharmacology evaluation of Althaea officinalis L. phytocompounds targeting Park2 for the management of Parkinson\u2019s disease"],"prefix":"10.1007","volume":"34","author":[{"given":"M.","family":"Heshetha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthineni","family":"Haneesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesan","family":"Karthick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkumar","family":"Thamarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Singamoorthy","family":"Amalraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"2296_CR1","doi-asserted-by":"crossref","unstructured":"Akki AJ, Patil SA, Hungund S et al (2024) Advances in Parkinson\u2019s disease research \u2013a computational network pharmacological approach. Int Immunopharmacol 139","DOI":"10.1016\/j.intimp.2024.112758"},{"key":"2296_CR2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.1c00998","author":"PR Arantes","year":"2021","unstructured":"Arantes PR, Pol\u00eato MD, Pedebos C, Ligabue-Braun R (2021) Making it rain: cloud-based molecular simulations for everyone. J Chem Inf Model. https:\/\/doi.org\/10.1021\/acs.jcim.1c00998","journal-title":"J Chem Inf Model"},{"key":"2296_CR3","doi-asserted-by":"crossref","unstructured":"Baimakhanova B, Sadanov A, Ratnikova I et al (2025) Phytochemical compounds and biomedical properties of Althaea officinalis. Pharm Pract (Granada). 23","DOI":"10.18549\/PharmPract.2025.3.3153"},{"key":"2296_CR4","doi-asserted-by":"crossref","unstructured":"Blagov A, Postnov A, Sukhorukov V et al (2024) Significance of mitochondrial dysfunction in the pathogenesis of Parkinson\u2019s disease. Front Biosci Landmark 29","DOI":"10.31083\/j.fbl2901036"},{"key":"2296_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00290","author":"GA Bonaterra","year":"2020","unstructured":"Bonaterra GA, Bronischewski K, Hunold P et al (2020) Anti-inflammatory and Anti-oxidative Effects of Phytohustil\u00ae and Root Extract of Althaea officinalis L. on Macrophages in vitro. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.00290","journal-title":"Front Pharmacol"},{"key":"2296_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-32633-3_1","volume":"1195","author":"HK Boyina","year":"2020","unstructured":"Boyina HK, Geethakhrishnan SL, Panuganti S et al (2020) In silico and in vivo studies on quercetin as potential anti-parkinson agent. Adv Exp Med Biol 1195:1\u201311. https:\/\/doi.org\/10.1007\/978-3-030-32633-3_1","journal-title":"Adv Exp Med Biol"},{"key":"2296_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-025-01585-y","author":"MR Chowdhury","year":"2025","unstructured":"Chowdhury MR, Reddy RVS, Nampoothiri NK et al (2025) Exploring bioactive natural products for treating neurodegenerative diseases: a computational network medicine approach targeting the estrogen signaling pathway in amyotrophic lateral sclerosis and Parkinson\u2019s disease. Metab Brain Dis. https:\/\/doi.org\/10.1007\/s11011-025-01585-y","journal-title":"Metab Brain Dis"},{"key":"2296_CR8","doi-asserted-by":"crossref","unstructured":"Fan N, Chen J, Wang J et al (2025) Bridging data and drug development: machine learning approaches for next-generation ADMET prediction. Drug Discov. Today 30","DOI":"10.1016\/j.drudis.2025.104487"},{"key":"2296_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27092834","author":"C Gnanaraj","year":"2022","unstructured":"Gnanaraj C, Sekar M, Fuloria S et al (2022) In silico molecular docking analysis of karanjin against Alzheimer\u2019s and Parkinson\u2019s diseases as a potential natural lead molecule for new drug design, development and therapy. Molecules. https:\/\/doi.org\/10.3390\/molecules27092834","journal-title":"Molecules"},{"key":"2296_CR10","doi-asserted-by":"crossref","unstructured":"Gouda NA, Elkamhawy A, Cho J (2022) Emerging therapeutic strategies for Parkinson\u2019s disease and future prospects: a 2021 update. Biomedicines 10","DOI":"10.3390\/biomedicines10020371"},{"key":"2296_CR11","doi-asserted-by":"publisher","unstructured":"Hang L, Thundyil J, Lim KL (2015) Mitochondrial dysfunction and Parkinson disease: a Parkin\u2013AMPK alliance in neuroprotection. Ann N Y Acad Sci 1350. https:\/\/doi.org\/10.1111\/nyas.12820","DOI":"10.1111\/nyas.12820"},{"key":"2296_CR12","doi-asserted-by":"publisher","first-page":"100726","DOI":"10.1016\/j.prmcm.2025.100726","volume":"18","author":"V Karthick","year":"2026","unstructured":"Karthick V, Venkatachalam DK, Amalraj S et al (2026) Multi-target immunomodulatory actions of Elaeagnus rhamnoides L.) A. Nelson phytocompounds on immune regulatory targets via integrative network pharmacology, docking, and molecular simulation. Pharmacol Res - Mod Chin Med 18:100726. https:\/\/doi.org\/10.1016\/j.prmcm.2025.100726","journal-title":"Pharmacol Res - Mod Chin Med"},{"key":"2296_CR13","doi-asserted-by":"crossref","unstructured":"Latif R, Nawaz T (2025) Medicinal plants and human health: a comprehensive review of bioactive compounds, therapeutic effects, and applications. Phytochem Rev","DOI":"10.1007\/s11101-025-10194-7"},{"key":"2296_CR14","doi-asserted-by":"crossref","unstructured":"Latif S, Jahangeer M, Maknoon Razia D et al (2021) Dopamine in Parkinson\u2019s disease. Clin Chim Acta 522","DOI":"10.1016\/j.cca.2021.08.009"},{"key":"2296_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4103\/NRR.NRR-D-24-00764","volume":"21","author":"X Lian","year":"2026","unstructured":"Lian X, Liu Z, Gan Z et al (2026) Targeting the glymphatic system to promote \u03b1-synuclein clearance: a novel therapeutic strategy for Parkinson\u2019s disease. Neural Regen Res 21:233\u2013247. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-00764","journal-title":"Neural Regen Res"},{"key":"2296_CR16","doi-asserted-by":"crossref","unstructured":"Lucchesi M, Biso L, Bonaso M et al (2025) Mitochondrial dysfunction in genetic and non-genetic Parkinson\u2019s disease. Int J Mol Sci 26","DOI":"10.3390\/ijms26094451"},{"key":"2296_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-014-0400-x","author":"KB Magalingam","year":"2015","unstructured":"Magalingam KB, Radhakrishnan A, Ramdas P, Haleagrahara N (2015) Quercetin glycosides induced neuroprotection by changes in the gene expression in a cellular model of Parkinson\u2019s disease. J Mol Neurosci. https:\/\/doi.org\/10.1007\/s12031-014-0400-x","journal-title":"J Mol Neurosci"},{"key":"2296_CR18","doi-asserted-by":"crossref","unstructured":"Malpartida AB, Williamson M, Narendra DP et al (2021) Mitochondrial Dysfunction and Mitophagy in Parkinson\u2019s disease: from mechanism to therapy. Trends Biochem Sci 46","DOI":"10.1016\/j.tibs.2020.11.007"},{"key":"2296_CR19","doi-asserted-by":"crossref","unstructured":"Narendra DP, Youle RJ (2024) The role of PINK1\u2013Parkin in mitochondrial quality control. Nat Cell Biol 26","DOI":"10.1038\/s41556-024-01513-9"},{"key":"2296_CR20","doi-asserted-by":"publisher","unstructured":"Odhiambo DO, Omosa LK, Njagi EC et al (2025) In-silico pharmacokinetics ADME\/Tox analysis of phytochemicals from genus Dracaena for their therapeutic potential. Sci Afr 29. https:\/\/doi.org\/10.1016\/j.sciaf.2025.e02796","DOI":"10.1016\/j.sciaf.2025.e02796"},{"key":"2296_CR21","doi-asserted-by":"publisher","unstructured":"Okoh VI, Campos HM, de Oliveira Ferreira PY et al (2024) Chrysin bonded to \u03b2-d-glucose tetraacetate enhances its protective effects against the neurotoxicity induced by aluminum in Swiss mice. J Pharm Pharmacol 76. https:\/\/doi.org\/10.1093\/jpp\/rgae011","DOI":"10.1093\/jpp\/rgae011"},{"key":"2296_CR22","doi-asserted-by":"publisher","first-page":"130030","DOI":"10.1016\/j.matchemphys.2024.130030","volume":"328","author":"B Padmavathy","year":"2024","unstructured":"Padmavathy B, Ebinezer BS, Amalraj S et al (2024) Cytotoxicity effects of Terminalia arjuna bark-derived nano-ZnO on MCF 7 cells and enhanced anti-breast cancer potency of its phytochemicals upon Zn-capping. Mater Chem Phys 328:130030. https:\/\/doi.org\/10.1016\/j.matchemphys.2024.130030","journal-title":"Mater Chem Phys"},{"key":"2296_CR23","doi-asserted-by":"crossref","unstructured":"Pathan I, Raza A, Sahu A et al (2025) Revolutionizing pharmacology: AI-powered approaches in molecular modeling and ADMET prediction. Med Drug Discov. 28","DOI":"10.1016\/j.medidd.2025.100223"},{"key":"2296_CR24","doi-asserted-by":"crossref","unstructured":"Perdig\u00e3o JM, Teixeira BJB, Carvalho-da-Silva V et al (2024) A critical analysis on the concentrations of phenolic compounds tested using in vitro and in vivo Parkinson\u2019s disease models. Crit Rev Food Sci Nutr 64","DOI":"10.1080\/10408398.2023.2171960"},{"key":"2296_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03526-5","author":"RM de Pereira","year":"2025","unstructured":"Pereira RM, Campos HM, de Oliveira Ferreira PY et al (2025) Glycosylation of chrysin with \u03b2-d-glucose tetraacetate (LQFM280) enhances its in vitro and in vivo neuroprotective effects against the toxicity induced by 3-nitropropionic acid. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-024-03526-5","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2296_CR26","doi-asserted-by":"crossref","unstructured":"Picca A, Guerra F, Calvani R et al (2021) Mitochondrial dysfunction, protein misfolding and neuroinflammation in parkinson\u2019s disease: Roads to biomarker discovery. Biomolecules 11","DOI":"10.3390\/biom11101508"},{"key":"2296_CR27","doi-asserted-by":"publisher","unstructured":"Rollinger JM, Hornick A, Langer T et al (2004) Acetylcholinesterase inhibitory activity of scopolin and scopoletin discovered by virtual screening of natural products. J Med Chem 47. https:\/\/doi.org\/10.1021\/jm049655r","DOI":"10.1021\/jm049655r"},{"key":"2296_CR28","doi-asserted-by":"crossref","unstructured":"Son A, Park J, Kim W et al (2024) Recent advances in omics, computational models, and advanced screening methods for drug safety and efficacy. Toxics 12","DOI":"10.3390\/toxics12110822"},{"key":"2296_CR29","doi-asserted-by":"publisher","DOI":"10.2174\/1389450120666191112155654","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji OR, Hadinezhad T, Fallah M et al (2019) The therapeutic potential of quercetin in Parkinson\u2019s disease: insights into its molecular and cellular regulation. Curr Drug Targets. https:\/\/doi.org\/10.2174\/1389450120666191112155654","journal-title":"Curr Drug Targets"},{"key":"2296_CR30","doi-asserted-by":"publisher","unstructured":"Venkataraman M, Rao GC, Madavareddi JK, Maddi SR (2025) Leveraging machine learning models in evaluating ADMET properties for drug discovery and development. https:\/\/doi.org\/10.5599\/admet.2772. ADMET DMPK 13:","DOI":"10.5599\/admet.2772"},{"key":"2296_CR31","doi-asserted-by":"publisher","DOI":"10.2174\/0125899775358899250726213130","author":"P Wal","year":"2025","unstructured":"Wal P, Vadera S, Aziz N et al (2025) Pharmacological activity of scopoletin: deciphering the potential of coumarins in cognitive dysfunction. Curr Drug Res Rev. https:\/\/doi.org\/10.2174\/0125899775358899250726213130","journal-title":"Curr Drug Res Rev"},{"key":"2296_CR32","doi-asserted-by":"crossref","unstructured":"Wang X, Le, Feng ST, Wang ZZ et al (2021) Parkin, an E3 ubiquitin ligase, plays an essential role in mitochondrial quality control in Parkinson\u2019s disease. Cell Mol Neurobiol 41","DOI":"10.1007\/s10571-020-00914-2"},{"key":"2296_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/fsn3.3455","author":"Z Wang","year":"2023","unstructured":"Wang Z, Jiang X, Zhang L, Chen H (2023) Protective effects of Althaea officinalis L. extract against N-diethylnitrosamine-induced hepatocellular carcinoma in male Wistar rats through antioxidative, anti-inflammatory, mitochondrial apoptosis and PI3K\/Akt\/mTOR signaling pathways. Food Sci Nutr. https:\/\/doi.org\/10.1002\/fsn3.3455","journal-title":"Food Sci Nutr"},{"key":"2296_CR34","doi-asserted-by":"crossref","unstructured":"Xiao B, Kuruvilla J, Tan EK (2022) Mitophagy and reactive oxygen species interplay in Parkinson\u2019s disease. NPJ Parkinsons Dis 8","DOI":"10.1038\/s41531-022-00402-y"},{"key":"2296_CR35","doi-asserted-by":"crossref","unstructured":"Zhang J, Li H, Zhang Y et al (2025) Computational toxicology in drug discovery: applications of artificial intelligence in ADMET and toxicity prediction. Brief Bioinform 26","DOI":"10.1093\/bib\/bbaf533"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02296-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02296-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02296-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:17:06Z","timestamp":1784704626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02296-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2296"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02296-1","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors declare that there is no competing interest between authors and organizations.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}